{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T09:22:46Z","timestamp":1682587366018},"reference-count":20,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2003,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            The identification of\n            <jats:italic>Helicobacter pylori<\/jats:italic>\n            -strain specific factors that correlate with clinical outcome has remained elusive. We investigated possible relationships between a group of\n            <jats:italic>H. pylori<\/jats:italic>\n            antigens and clinical outcome and compared an immunoblot assay kit (HelicoBlot, version 2.1 [HB 2.1]; Genelabs Diagnostics) with an established serological test, the high-molecular-weight cell-associated protein test (HM-CAP). We used sera from 156 Thai patients with different disease presentations, including 43 patients with gastric cancer, 64 patients with gastric ulcer, and 49 patients with nonulcer dyspepsia (NUD). HB 2.1 was compared to HM-CAP as a diagnostic test for\n            <jats:italic>H. pylori<\/jats:italic>\n            infection. The seroprevalence of\n            <jats:italic>H. pylori<\/jats:italic>\n            was significantly higher among gastric cancer patients than among patients with NUD (93 and 67%, respectively;\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.01). Among the\n            <jats:italic>H. pylori<\/jats:italic>\n            -seropositive patients, the presence of the antibody to the 37,000-molecular-weight antigen (37K antigen) was inversely related to the presence of gastric cancer (e.g., for gastric cancer patients compared with NUD patients, odds ratio [OR] = 0.28 and 95% confidence interval [CI] = 0.1 to 0.8). The presence of antibody to the 35K antigen was higher in gastric ulcer patients than in NUD patients (OR = 11.5; 95% CI = 2.4 to 54.3). The disease associations of antibodies to the 35K and 37K antigens are consistent with the possibility that these antigens are either indirect markers for\n            <jats:italic>H. pylori<\/jats:italic>\n            -related diseases or have specific active or protective roles in\n            <jats:italic>H. pylori<\/jats:italic>\n            -related diseases.\n          <\/jats:p>","DOI":"10.1128\/cdli.10.6.1025-1028.2003","type":"journal-article","created":{"date-parts":[[2003,11,7]],"date-time":"2003-11-07T20:11:30Z","timestamp":1068235890000},"page":"1025-1028","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":12,"title":["Relation between Seroreactivity to Low-Molecular-Weight\n            <i>Helicobacter pylori<\/i>\n            -Specific Antigens and Disease Presentation"],"prefix":"10.1128","volume":"10","author":[{"given":"Ratha-Korn","family":"Vilaichone","sequence":"first","affiliation":[{"name":"Gastroenterology Unit, Department of Medicine, Thammasat University Hospital, Pathumthani"},{"name":"Gastroenterology Unit, Department of Medicine, Chulalongkorn University Hospital"},{"name":"Gastroenterology Unit, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand"},{"name":"Department of Medicine, Veterans Affairs Medical Center, and Baylor College of Medicine, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varocha","family":"Mahachai","sequence":"additional","affiliation":[{"name":"Gastroenterology Unit, Department of Medicine, Thammasat University Hospital, Pathumthani"},{"name":"Gastroenterology Unit, Department of Medicine, Chulalongkorn University Hospital"},{"name":"Gastroenterology Unit, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand"},{"name":"Department of Medicine, Veterans Affairs Medical Center, and Baylor College of Medicine, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chomsri","family":"Kositchaiwat","sequence":"additional","affiliation":[{"name":"Gastroenterology Unit, Department of Medicine, Thammasat University Hospital, Pathumthani"},{"name":"Gastroenterology Unit, Department of Medicine, Chulalongkorn University Hospital"},{"name":"Gastroenterology Unit, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand"},{"name":"Department of Medicine, Veterans Affairs Medical Center, and Baylor College of Medicine, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Y.","family":"Graham","sequence":"additional","affiliation":[{"name":"Gastroenterology Unit, Department of Medicine, Thammasat University Hospital, Pathumthani"},{"name":"Gastroenterology Unit, Department of Medicine, Chulalongkorn University Hospital"},{"name":"Gastroenterology Unit, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand"},{"name":"Department of Medicine, Veterans Affairs Medical Center, and Baylor College of Medicine, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Yamaoka","sequence":"additional","affiliation":[{"name":"Gastroenterology Unit, Department of Medicine, Thammasat University Hospital, Pathumthani"},{"name":"Gastroenterology Unit, Department of Medicine, Chulalongkorn University Hospital"},{"name":"Gastroenterology Unit, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand"},{"name":"Department of Medicine, Veterans Affairs Medical Center, and Baylor College of Medicine, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.4.931-936.1998"},{"key":"e_1_3_2_3_2","first-page":"2111","volume":"55","year":"1995","unstructured":"Blazer, M. J., G. I. Perez-Perez, H. Kleanhous, T. L. Cover, R. M. Peek, P. H. Chyou, G. N. Stemmermann, and A. Nomura. 1995. Infection with Helicobacter pylori strains possesing cagA is associated with an increase risk of developing adenocarcinoma of the stomach. Cancer Res.55:2111-2115.","journal-title":"Cancer Res."},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1523-5378.2002.00089.x","volume":"7","year":"2002","unstructured":"Chua, T. S., K. M. Fock, Y. H. Chan, S. Dhamodaran, C. S. Sim, T. M. Ng, and E. K. Teo. 2002. Seroreactivity to 19.5-kDa antigen in combination with absence of seroreactivity to 35-kDa antigen is associated with an increased risk of gastric adenocarcinoma. Helicobacter7:257-264.","journal-title":"Helicobacter"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1056\/NEJM198912073212302","volume":"321","year":"1989","unstructured":"Dooley, C. P., H. Cohen, P. L. Fitzgibbons, M. Bauer, M. D. Appleman, G. I. Perez-Perez, and M. J. Blaser. 1989. Prevalence of Helicobacter pylori infection and histiologic gastritis in an asymptomatic person. N. Engl. J. Med.321:1562-1566.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_6_2","first-page":"297","volume":"82","year":"1987","unstructured":"Hazell S. L., W. B. Hennessy, T. J. Borody, J. Carrick, M. Ralston, L. Brady, and A. Lee. 1987. Campylobacter pyloridis gastritis. II. Distribution of bacteria and associated inflammation in the gastroduodenal environment. Am. J. Gastroenterol.82:297-301.","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_3_2_7_2","first-page":"1167","volume":"1148","year":"1998","unstructured":"Huang, J. Q., S. Sridhar, Y. Chen, and R. H. Hunt. 1998. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology1148:1167-1169.","journal-title":"Gastroenterology"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/jnci\/87.23.1777","volume":"87","year":"1995","unstructured":"Kuipers, E. J., G. I. Perez-Perez, S. G. Meuwissen, and M. J. Blaser. 1995. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J. Natl. Cancer Inst.87:1777-1780.","journal-title":"J. Natl. Cancer Inst."},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1572-0241.1998.00227.x","volume":"93","year":"1998","unstructured":"Navaglia, F., D. Basso, M. G. Piva, L. Brigato, A. Stefani, N. Dal Bo, F. Di Mario, M. Rugge, and M. Plebani. 1998. Helicobacter pylori cytotoxic genotype is associated with peptic ulcer and influences serology. Am. J. Gastroenterol.93:227-230.","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.12.4753-4756.2002"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/gut.40.3.297","volume":"40","year":"1997","unstructured":"Parsonnet, J., G. D. Friedman, N. Orentreich, and H. Vogelman. 1997. Risk of gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut40:297-301.","journal-title":"Gut"},{"key":"e_1_3_2_12_2","first-page":"473","volume":"2","year":"1989","unstructured":"Robey-Cafferty, S. S., J. Y. Ro, and K. R. Cleary. 1989. The prevalence of Campylobacter pylori in gastric biopsy from cancer patients. Mod. Pathol.2:473-476.","journal-title":"Mod. Pathol."},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1111\/j.1572-0241.1999.1138_a.x","volume":"94","year":"1999","unstructured":"Rudi, J., A. Rudy, M. Maiwald, D. Kuck, A. Sieg, and W. Stremmel. 1999. Direct determination of Helicobacter pylori vacA genotypes and cagA gene in gastric biopsies and relationship to gastrointestinal diseases. Am. J. Gastroenterol.94:1525-1531.","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1572-0241.1998.00375.x","volume":"93","year":"1998","unstructured":"Sozzi, M., M. Valentini, N. Figura, P. De Paoli, R. M. Tedeschi, A. Gloghini, D. Serraino, M. Poletti, and A. Carbone. 1998. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of cagA status. Am. J. Gastroenterol.93:375-379.","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_3_2_15_2","first-page":"475","volume":"84","year":"2001","unstructured":"Thong-Ngam, D., P. Tangkijvanich, V. Mahachai, and P. Kullavanijaya. 2001. Current status of gastric cancer in Thai patients. J. Med. Assoc. Thai.84:475-482.","journal-title":"J. Med. Assoc. Thai."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.37.12.4150-4152.1999"},{"key":"e_1_3_2_17_2","first-page":"497","volume":"17","year":"2001","unstructured":"Vilaichone R. K., and V. Mahachai. 2001. Gastric cancer. Clinic17:497-504.","journal-title":"Clinic"},{"key":"e_1_3_2_18_2","first-page":"889","volume":"41","year":"1997","unstructured":"Wisedopas, N., P. Tangkijvanich, and P. Suwanagool. 1997. Gastric cancer: relation between histologic subtypes, location and Helicobacter pylori infection. Chula. Med. J.41:889-899.","journal-title":"Chula. Med. J."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1023\/A:1018850412148","volume":"43","year":"1998","unstructured":"Yamaoka, Y., T. Kodama, D. Y. Graham, and K. Kashima. 1998. Search for putative virulence factors of Helicobacter pylori: the low-molecular-weight (33-35 K) antigen. Dig. Dis. Sci.43:1482-1487.","journal-title":"Dig. Dis. Sci."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.37.7.2274-2279.1999"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1046\/j.1523-5378.2001.00017.x","volume":"6","year":"2001","unstructured":"Yamaoka, Y., T. Kodama, M. Kita, J. Imanishi, K. Kashima, and D. Y. Graham. 2001. Relation between cytokines and Helicobacter pylori in gastric cancer. Helicobacter6:116-124.","journal-title":"Helicobacter"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.10.6.1025-1028.2003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.10.6.1025-1028.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:33:42Z","timestamp":1627590822000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CDLI.10.6.1025-1028.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["10.1128\/CDLI.10.6.1025-1028.2003"],"URL":"https:\/\/doi.org\/10.1128\/cdli.10.6.1025-1028.2003","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,11]]},"assertion":[{"value":"2003-06-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-08-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}